Product image of RITALIN LA 30mg (Methylphenidate hydrochloride ) 30mg Capsule supplied by GNH India

RITALIN LA 30mg

Active Ingredient:
Methylphenidate hydrochloride
Form:
Capsule
Brand:
RITALIN LA
Origin:
Switzerland

RITALIN LA 30mg (Methylphenidate hydrochloride Capsule) 30mg

Methylphenidate hydrochloride, the active ingredient in RITALIN LA 30mg, is a central nervous system stimulant presented as a 30mg extended-release capsule for oral use. It is primarily used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. GNH India supplies RITALIN LA 30mg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

RITALIN LA 30mg is a well-established medication in the management of ADHD, helping to improve focus, concentration, and impulse control. It is part of a comprehensive treatment plan that often includes behavioral therapy and educational support.

Strength

30mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

NOVARTIS PHARMA SCHWEIZ

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

RITALIN LA 30mg is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

  • ADHD: Improves attention, concentration, and reduces impulsive behavior in individuals with ADHD.
  • Narcolepsy: Off-label use in some regions to manage symptoms of narcolepsy, such as excessive daytime sleepiness.
  • ADHD in Children and Adolescents: Used in children aged 6 to 18 years when other non-pharmacological treatments have not been effective.
  • ADHD in Adults: May be continued from childhood or initiated in adults who have not previously used methylphenidate.

How It Works

  • RITALIN LA 30mg works by inhibiting the reuptake of dopamine and norepinephrine in the brain, increasing their concentrations in the synaptic cleft. This enhances neurotransmission in the prefrontal cortex and striatum, areas critical for attention, impulse control, and executive function. The extended-release formulation ensures a prolonged effect, providing symptom control throughout the day.

Side Effects

RITALIN LA 30mg may cause various side effects, ranging from common to serious.

Common Side Effects

  • Decreased appetite
  • Insomnia
  • Headache
  • Nervousness
  • Increased heart rate
  • Dry mouth
  • Stomach pain

Serious or Rare Side Effects

  • Cardiovascular issues, including increased blood pressure and heart rate
  • Psychiatric symptoms, such as hallucinations, mania, or aggression
  • Tics or exacerbation of Tourette's syndrome
  • Growth suppression in children
  • Allergic reactions, including rash and anaphylaxis
  • Seizures

Precautions & Warnings

RITALIN LA 30mg should be used with caution and under medical supervision.

  • Prescription Use: Only use as prescribed by a healthcare professional experienced in treating ADHD.
  • Cardiovascular Monitoring: Regular monitoring of heart rate and blood pressure is recommended.
  • Growth Monitoring: Children using RITALIN LA should have their growth regularly monitored.
  • Psychiatric Monitoring: Monitor for new or worsening psychiatric symptoms, including mood changes and hallucinations.
  • Substance Abuse Potential: Has a potential for abuse and dependence; use with caution in individuals with a history of substance abuse.
  • Store below 25°C: Keep in the original pack, protect from moisture.

Avoid Interactions

RITALIN LA 30mg may interact with other medications, necessitating careful management.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): Concurrent use can lead to hypertensive crisis.
  • Antidepressants: May increase the risk of serotonin syndrome.
  • Stimulants: Increased risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: May reduce the effectiveness of blood pressure medications.
  • Antipsychotics: May diminish the therapeutic effects of RITALIN LA.
  • Acidifying or Alkalizing Agents: Can alter the excretion rate of methylphenidate.

Frequently Asked Questions

RITALIN LA 30mg is primarily used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It helps improve focus, concentration, and reduce impulsive behavior. It is also sometimes used off-label for narcolepsy.

Methylphenidate works by inhibiting the reuptake of dopamine and norepinephrine in the brain, increasing their concentrations in the synaptic cleft. This enhances neurotransmission in areas critical for attention, impulse control, and executive function.

The dosage of RITALIN LA 30mg is determined by a healthcare professional based on individual needs and response to treatment. It is typically started at a low dose and adjusted as necessary.

RITALIN LA 30mg is classified as a Pregnancy Category C drug, meaning it should be used during pregnancy only if the potential benefits outweigh the risks. It is not recommended during breastfeeding due to potential risks to the infant.

To order RITALIN LA 30mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then provide pricing, availability, shipping, and import paperwork.

RITALIN LA 30mg is an extended-release formulation of methylphenidate, providing prolonged symptom control throughout the day. It is similar to other stimulant medications like amphetamines but has a different chemical structure and mechanism of action.

RITALIN LA 30mg should be stored below 25°C, in the original pack, and protected from moisture. It should be kept out of reach of children and pets.

RITALIN LA 30mg is administered orally, typically once daily in the morning. The capsule should be swallowed whole with water and not crushed or chewed to maintain the extended-release properties.

The most serious risks include cardiovascular issues, psychiatric symptoms, tics or exacerbation of Tourette's syndrome, growth suppression in children, allergic reactions, and seizures. Regular monitoring by a healthcare professional is essential.

RITALIN LA 30mg should not be used by individuals with severe anxiety, agitation, or a history of substance abuse. It is also contraindicated in those with certain cardiovascular conditions, glaucoma, or a history of tics or Tourette's syndrome.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate hydrochloride

Ritalin LA

Ritalin LA

30mg Capsule
Ritalin LA 20 mg/1

Ritalin LA 20 mg/1

20 mg/1 CAPSULE, EXTENDED RELEASE
Ritalin LA 30 mg/1

Ritalin LA 30 mg/1

30 mg/1 CAPSULE, EXTENDED RELEASE
Ritalin LA 40 mg/1

Ritalin LA 40 mg/1

40 mg/1 CAPSULE, EXTENDED RELEASE

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT